National University of Singapore
MSc in Health Economics and Outcomes Research
Singapore, Singapore
MSc
DURATION
24 months
LANGUAGES
English
PACE
Full time, Part time
APPLICATION DEADLINE
15 Dec 2025
EARLIEST START DATE
Aug 2026
TUITION FEES
SGD 58,860 *
STUDY FORMAT
On-Campus
* non-alumni international | alumni international: 47,088 SGD | Singapore citizens or Singapore permanent residents: 35,316 SGD (including 9% GST)
Asia’s Premier MSc in HEOR
The only specialised MScHEOR in Singapore, our programme is tailored to Asian healthcare systems. Designed to fill the regional talent gap in health economics and outcomes research (HEOR), health technology assessment (HTA), and market access, it offers graduates strong career prospects across South-East Asia and beyond.
Career-Driven Curriculum with Real-World Impact
Students will gain hands-on experience through capstone projects, and build practical skills in areas like cost-effectiveness modelling, market access strategy, and patient-centred outcomes research - directly applicable in the pharmaceutical and , medtech industries, government, and consulting.
NUS: A Globally Recognised Institution
The National University of Singapore (NUS) is ranked first in Asia and eighth globally in the QS World University Rankings 2026. As a leading institution in public health and medicine, an NUS qualification provides graduates with opportunities in medical innovation, regulation, and policy evaluation.
Flexible & Work-Friendly Learning Structure
Classes are delivered either in intensive in-person blocks of 1–2 weeks or through online sessions. This allows students to learn from any location while accommodating a wide range of professional commitments.
Teaching Team Blends Academic Excellence & Deep Practice Experience
NUS faculty on the programme are leading HEOR researchers with national and global influence. They are joined by industry and government experts who bring real-world experience and practical insight to the classroom.
The MScHEOR programme is a 40-unit degree completed over one year (full-time) or two years (part-time), comprising 24 units of core courses and 16 units of electives. A NUS course typically counts as 4 units. The MSc will be awarded to students who successfully complete all the coursework requirements for the programme with a minimum overall GPA of 3.00 or higher.
The core modules are designed to establish a strong foundation in the essential principles and methodologies of Health Economics and Outcomes Research. Students will gain a comprehensive understanding of key concepts, analytical techniques, and economic evaluation methods necessary for conducting rigorous HEOR studies and contributing effectively to healthcare decision-making.
The suite of elective modules allows students to tailor their learning to specific interests, offering advanced knowledge and skills in various specialised areas. Through these electives, students can deepen their expertise and enhance their ability to address complex challenges in healthcare decision-making and policy, ensuring they are well-prepared to contribute meaningfully to the field.
| For Full-Time Students | |
|---|---|
| Semester 1 |
|
| Semester 2 |
|
| For Part-Time Students | |
|---|---|
| Year 1 / Semester 1 |
|
| Year 1 / Semester 2 |
|
| Year 2 / Semester 1 |
|
| Year 2 / Semester 2 |
|
See below for the list of electives:
Part-time students planning to take the following Elective Courses must first complete HE5002 Introduction to HEOR in their first semester, as it is a prerequisite for these courses:
- HE5105 Distributional Cost-Effectiveness Analysis
- HE5201 HTA – From Practice to Policy
- HE5202 Market Access in MedTech
For the following core courses (offered in Semester 1), the delivery mode is in-person.
- HE5001 Evidence synthesis for HEOR
- HE5005 Capstone I
For elective courses (offered in Semester 2), the default delivery mode is in-person, unless otherwise stated.
Career Prospects
Public Sector
Health Technology Assessment agencies (e.g., ACE in Singapore), Ministries of Health, healthcare clusters (e.g., NUHS, NHG, Singhealth), and statutory bodies (e.g., Health Promotion Board).
Private Sector
HEOR consultancies, pharmaceutical & MedTech companies, healthcare payers & insurers.
Academia
Universities, government research institutes, and non-governmental think tanks.